Literature DB >> 30232270

Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis.

Chang-Min Lee1, Soo Jung Cho2, Won-Kyung Cho3, Jin Wook Park1, Jae-Hyun Lee4, Augustine M Choi2, Ivan O Rosas5, Ming Zheng6, Gary Peltz6, Chun Geun Lee1, Jack A Elias1,7.   

Abstract

The pathogenetic mechanisms underlying the pathologic fibrosis in diseases such as idiopathic pulmonary fibrosis (IPF) are poorly understood. To identify genetic factors affecting susceptibility to IPF, we analyzed a murine genetic model of IPF in which a profibrotic cytokine (TGF-β1) was expressed in the lungs of 10 different inbred mouse strains. Surprisingly, the extent of TGF-β1-induced lung fibrosis was highly strain dependent. Haplotype-based computational genetic analysis and gene expression profiling of lung tissue obtained from fibrosis-susceptible and -resistant strains identified laminin α1 (Lama1) as a genetic modifier for susceptibility to IPF. Subsequent studies demonstrated that Lama1 plays an important role in multiple processes that affect the pulmonary response to lung injury and susceptibility to fibrosis, which include: macrophage activation, fibroblast proliferation, myofibroblast transformation, and the production of extracellular matrix. Also, Lama1 mRNA expression was significantly increased in lung tissue obtained from IPF patients. These studies identify Lama1 as the genetic modifier of TGF-β1 effector responses that significantly affects the development of pulmonary fibrosis.

Entities:  

Keywords:  Fibrosis; Pulmonology

Mesh:

Substances:

Year:  2018        PMID: 30232270      PMCID: PMC6237225          DOI: 10.1172/jci.insight.99574

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  60 in total

1.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.

Authors:  P J Sime; Z Xing; F L Graham; K G Csaky; J Gauldie
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Lung-specific loss of α3 laminin worsens bleomycin-induced pulmonary fibrosis.

Authors:  Luisa I Morales-Nebreda; Micah R Rogel; Jessica L Eisenberg; Kevin J Hamill; Saul Soberanes; Recep Nigdelioglu; Monica Chi; Takugo Cho; Kathryn A Radigan; Karen M Ridge; Alexander V Misharin; Alex Woychek; Susan Hopkinson; Harris Perlman; Gokhan M Mutlu; Annie Pardo; Moises Selman; Jonathan C R Jones; G R Scott Budinger
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

Review 3.  Macrophages in Tissue Repair, Regeneration, and Fibrosis.

Authors:  Thomas A Wynn; Kevin M Vannella
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

Review 4.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?

Authors:  A B Roberts; E Piek; E P Böttinger; G Ashcroft; J B Mitchell; K C Flanders
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 6.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

7.  Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.

Authors:  Kazuyoshi Kuwano; Takashige Maeyama; Ichiro Inoshima; Kiyoshi Ninomiya; Naoki Hagimoto; Michihiro Yoshimi; Masaki Fujita; Norio Nakamura; Kamon Shirakawa; Nobuyuki Hara
Journal:  Respirology       Date:  2002-03       Impact factor: 6.424

8.  Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease.

Authors:  Judith C W Mak; Moira M W Chan-Yeung; Siu P Ho; Kin S Chan; Kahlin Choo; Kwok S Yee; Chi H Chau; Amy H K Cheung; Mary S M Ip
Journal:  Respir Med       Date:  2009-01-31       Impact factor: 3.415

9.  Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation.

Authors:  Malia M Edwards; Elmina Mammadova-Bach; Fabien Alpy; Annick Klein; Wanda L Hicks; Michel Roux; Patricia Simon-Assmann; Richard S Smith; Gertraud Orend; Jiang Wu; Neal S Peachey; Jürgen K Naggert; Olivier Lefebvre; Patsy M Nishina
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

10.  Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis.

Authors:  Yang Zhou; Jae-Young Lee; Chang-Min Lee; Won-Kyung Cho; Min-Jong Kang; Jonathan L Koff; Pyeong-Oh Yoon; Jeiwook Chae; Han-Oh Park; Jack A Elias; Chun Geun Lee
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

View more
  5 in total

1.  Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical Illness.

Authors:  Carmen Mikacenic; Pavan Bhatraju; Cassianne Robinson-Cohen; Susanna Kosamo; Alison E Fohner; Victoria Dmyterko; S Alice Long; Karen Cerosaletti; Carolyn S Calfee; Michael A Matthay; Keith R Walley; James A Russell; Jason D Christie; Nuala J Meyer; David C Christiani; Mark M Wurfel
Journal:  Crit Care Med       Date:  2022-03-01       Impact factor: 7.598

2.  Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

Authors:  Jae-Hyun Lee; Chang-Min Lee; Joyce H Lee; Mun-Ock Kim; Jin Wook Park; Suchitra Kamle; Bedia Akosman; Erica L Herzog; Xue Yan Peng; Jack A Elias; Chun Geun Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

3.  Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment.

Authors:  Fanrui Mo; Ying Luo; Yuluan Yan; Juan Li; Shayi Lai; Weifeng Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

Review 4.  Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis.

Authors:  Suh-Young Lee; Chang-Min Lee; Bing Ma; Suchitra Kamle; Jack A Elias; Yang Zhou; Chun Geun Lee
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

Review 5.  Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases.

Authors:  Kaj E C Blokland; Simon D Pouwels; Michael Schuliga; Darryl A Knight; Janette K Burgess
Journal:  Clin Sci (Lond)       Date:  2020-10-30       Impact factor: 6.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.